Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 1.46% is in line with its 5-year average of 1.50%, around the middle of its 5-year range (0.37%–2.88%).
As of the fiscal period ended Tuesday, June 30, 2026. 16.59% below its 12-month average of 1.75%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 1.46%.
DEBT TO ASSETS RATIO
1.46%
DEBT TO ASSETS RATIO AVG TTM
1.75%
DEBT TO ASSETS RATIO AVG 3Y
1.84%
DEBT TO ASSETS RATIO AVG 5Y
1.50%
DEBT TO ASSETS RATIO AVG 10Y
N/A
DEBT TO ASSETS RATIO AVG 15Y
N/A
DEBT TO ASSETS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-16.59%
CURRENT VS 3Y AVG
-20.97%
CURRENT VS 5Y AVG
-2.65%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+1517.85%
vs the sector median at left
Tyra Biosciences, Inc.
Market Cap
$1.21B
Debt to Assets Ratio
1.46%
TTM Avg
1.75%
3Y Avg
1.84%
5Y Avg
1.50%
Market Cap
$1.20B
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.22B
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.18B
Debt to Assets Ratio
0.45%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$1.24B
Debt to Assets Ratio
0.01%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tyra Biosciences, Inc. (TYRA) | $1.21B | 1.46% | 1.75% | 1.84% | 1.50% |
| Kardigan, Inc. (KARD)vs › | $1.21B | 0.02% | N/A | N/A | N/A |
| Damora Therapeutics, Inc. (DMRA)vs › | $1.20B | 0.00% | N/A | N/A | N/A |
| Innovage Holding Corp. (INNV)vs › | $1.22B | 0.16% | N/A | N/A | N/A |
| Cronos Group Inc. (CRON)vs › | $1.23B | 0.00% | N/A | N/A | N/A |
| MannKind Corporation (MNKD)vs › | $1.18B | 0.45% | N/A | N/A | N/A |
| Omada Health (OMDA)vs › | $1.23B | 0.00% | N/A | N/A | N/A |
| ORIC Pharmaceuticals, Inc. (ORIC)vs › | $1.24B | 0.01% | N/A | N/A | N/A |
| Nektar Therapeutics (NKTR)vs › | $1.14B | 0.12% | N/A | N/A | N/A |
| Amphastar Pharmaceuticals, Inc. (AMPH)vs › | $1.14B | 0.39% | N/A | N/A | N/A |
Debt/Assets
1.5%
Debt/Equity
0.02
Current Ratio
14.91
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 1.46% |
| 2026-03-31 | 1.38% |
| 2025-12-31 | 2.06% |
| 2025-09-30 | 1.96% |
| 2025-06-30 | 1.87% |
| 2025-03-31 | 1.78% |
| 2024-12-31 | 1.71% |
| 2024-09-30 | 1.66% |
| 2024-06-30 | 1.63% |
| 2024-03-31 | 1.60% |
| 2023-12-31 | 2.88% |
| 2023-09-30 | 2.56% |
| 2023-06-30 | 2.43% |
| 2023-03-31 | 1.01% |
| 2022-12-31 | 0.99% |
| 2022-09-30 | 0.96% |
| 2022-06-30 | 0.93% |
| 2022-03-31 | 0.90% |
| 2021-12-31 | 0.39% |
| 2021-09-30 | 0.37% |
| 2021-06-30 | 0.88% |
| 2021-03-31 | 110.97% |
| 2020-12-31 | 0.89% |
